A carregar...
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant (SOT) recipients, where primary infection or reactivation is associated with increased morbidity and mortality. Antiviral drugs are...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556539/ https://ncbi.nlm.nih.gov/pubmed/31239725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S180908 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|